Interventional Oncology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00 – $ 8,900.00

Interventional Oncology Market: By Product (Embolization Devices (Radioembolic Agents, Non-Radio embolic Agents(Microspheres, Coated Beads, Microparticles)), Ablation Devices (Radiofrequency (RF) Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Other Ablation Devices), Support Devices (Microcatheters, Guidewires), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization), By Cancer Type (Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, Other Cancers), By End User (Hospitals, Ambulatory Surgery Centers, Research & Academic Institutes) and Geograpy

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Category: Healthcare

Description
Table Of Content
Company Profile

Report

Description

Interventional Oncology Market size was valued at USD 2.1 billion in 2021. It is expected to reach a value of USD 3.2 billion by 2028, growing at a CAGR of 6.8% from 2022 to 2028. The global market provides a detailed overview of the Interventional Oncology Market, which has been segmented by product, ablation device, support devices, procedure, cancer type, and end user. The interventional oncology market has been segmented into In Embolization Devices (Radioembolic Agents, Non-Radio embolic Agents (Microspheres, Coated Beads, Microparticles). The Embolization Devices segment is likely the most significant and fastest-growing segment in various products. By ablation devices, the interventional oncology market has been segmented into Radiofrequency (RF) Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Other Ablation Devices. The Radiofrequency (RF) Ablation Devices are expected to account for a significant revenue share during the forecast period. Support devices have segmented the interventional oncology market into Microcatheters, Guidewires. The Microcatheters accounted for a substantial revenue share in 2021. By Procedure, the interventional oncology market has been segmented into Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization. Thermal Tumor Ablation is expected to hold a significant revenue share during the forecast period. The interventional oncology market has been segmented by cancer types: Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, and Other Cancers. The liver cancer segment holds the largest revenue share of the interventional oncology market. Based on the End User, Interventional Oncology is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. The Hospitals segment is predicted to register the fastest growth rate during the forecast period, according to precision business insights.

Key development:

In 2021, Boston Scientific (US) launched the TheraSphere Y-90 Glass Microspheres.

Interventional Oncology Market

MARKET SUMMARY

6.8%

Study Period– 2022-2028
Base Year– 2021
CAGR– 6.8%
Largest Market– North American
Fastest Growing Market– Asia-Pacific

Interventional Oncology Market

The Interventional Oncology Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
The Interventional Oncology Market is segmented based on product, procedure, cancer type, end user and geography.

Key Players

Boston Scientific Corporation
Medtronic PLC
Terumo Corporation
Merit Medical Systems Inc.
CR Bard Inc.

Interventional Oncology Market Drivers

According to the World Health Organization (WHO), cancer kills 8.3 million people annually, with 70 % of new cancer cases likely to be recorded in the next 20 years. A rise in cancer patients is expected to be a significant market driver.

North America Got Significant Share

Interventional Oncology Market

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The interventional oncology market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
The interventional oncology market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The interventional oncology market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The interventional oncology market report tracks recent innovations, key developments, and start-up details that are actively working in the market
The interventional oncology market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Interventional Oncology Market Segmentation

Product

Embolization Devices
Ablation Devices
Support Devices

Procedure

Thermal Tumor Ablation
Non-Thermal Tumor Ablation
Transcatheter Arterial Chemoembolization
Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
Transcatheter Arterial Embolization/Bland Embolization

Cancer Type

Liver Cancer
Lung Cancer
Bone Metastasis
Kidney Cancer
Breast Cancer
Prostate Cancer
Other Cancers

End User

Hospitals
Ambulatory Surgery Centers
Research & Academic Institutes

Location

GEOGRAPHY

Frequently Asked Questions

The Interventional Oncology Market is projected to expand at a CAGR of 6.8% during the forecast period

The major global Interventional Oncology market players are Medtronic, AngioDynamics, HealthTronics, Boston Scientific, J&J, BD, Teleflex, Terumo, Cook Medical, and Merit Medical.

North American is the fastest-growing region for Interventional Oncology Market

Report

Table Of Content

1. Executive Summary

2. Global Interventional Oncology Market Introduction

2.1. Global Interventional Oncology Market – Taxonomy

2.2. Global Interventional Oncology Market –Definitions

2.2.1. By Product

2.2.2. By Procedure

2.2.3. By Cancer Type

2.2.4. By End User

2.2.5. By Region

3. Global Interventional Oncology Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Interventional Oncology Market Dynamic Factors – Impact Analysis

3.6. Global Interventional Oncology Market – Competition Landscape

4. Global Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028

4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Interventional Oncology Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1. Embolization Devices

5.1.1. Radioembolic Agents

5.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.1.3. Market Opportunity Analysis

5.1.2. Non-Radio embolic Agents

5.1.2.1. Microspheres

5.1.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.2.1.3. Market Opportunity Analysis

5.1.2.2. Coated Beads

5.1.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.2.2.3. Market Opportunity Analysis

5.1.2.3. Microparticles

5.1.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.2.3.3. Market Opportunity Analysis

5.2. Ablation Devices

5.2.1. Radiofrequency (RF) Ablation Devices

5.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.1.3. Market Opportunity Analysis

5.2.2. Microwave Ablation Devices

5.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.2.3. Market Opportunity Analysis

5.2.3. Cryoablation Devices

5.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3.3. Market Opportunity Analysis

5.2.4. Other Ablation Devices

5.2.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.4.3. Market Opportunity Analysis

5.3. Support Devices

5.3.1. Microcatheters

5.3.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.1.3. Market Opportunity Analysis

5.3.2. Guidewires

5.3.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.2.3. Market Opportunity Analysis

6. Global Interventional Oncology Market, By Procedure, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.1. Thermal Tumor Ablation

6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Non-Thermal Tumor Ablation

6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Transcatheter Arterial Chemoembolization

6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Transcatheter Arterial Embolization/Bland Embolization

6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

7. Global Interventional Oncology Market, By Cancer Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.1. Liver Cancer

7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Lung Cancer

7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Bone Metastasis

7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Kidney Cancer

7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Breast Cancer

7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

7.6. Prostate Cancer

7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.6.3. Market Opportunity Analysis

7.7. Other Cancers

7.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.7.3. Market Opportunity Analysis

8. Global Interventional Oncology Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.1. Hospitals

8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Ambulatory Surgery Centers

8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Research & Academic Institutes

8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

9. Global Interventional Oncology Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.1. North America

9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Europe

9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Asia-Pacific

9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

9.4. Latin America

9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.4.3. Market Opportunity Analysis

9.5. Middle East and Africa

9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.5.3. Market Opportunity Analysis

9.6. Global Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Region, 2022-2028

10. North America Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

10.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Embolization Devices

10.1.1.1. Radioembolic Agents

10.1.1.2. Non-Radio embolic Agents

10.1.1.2.1. Microspheres

10.1.1.2.2. Coated Beads

10.1.1.2.3. Microparticles

10.1.2. Ablation Devices

10.1.2.1. Radiofrequency (RF) Ablation Devices

10.1.2.2. Microwave Ablation Devices

10.1.2.3. Cryoablation Devices

10.1.2.4. Other Ablation Devices

10.1.3. Support Devices

10.1.3.1. Microcatheters

10.1.3.2. Guidewires

10.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Thermal Tumor Ablation

10.2.2. Non-Thermal Tumor Ablation

10.2.3. Transcatheter Arterial Chemoembolization

10.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

10.2.5. Transcatheter Arterial Embolization/Bland Embolization

10.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Liver Cancer

10.3.2. Lung Cancer

10.3.3. Bone Metastasis

10.3.4. Kidney Cancer

10.3.5. Breast Cancer

10.3.6. Prostate Cancer

10.3.7. Other Cancers

10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.4.1. Hospitals

10.4.2. Ambulatory Surgery Centers

10.4.3. Research & Academic Institutes

10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.5.1. USA

10.5.2. Canada

10.6. North America Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028

10.7. North America Interventional Oncology Market Dynamics – Trends

11. Europe Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Embolization Devices

11.1.1.1. Radioembolic Agents

11.1.1.2. Non-Radio embolic Agents

11.1.1.2.1. Microspheres

11.1.1.2.2. Coated Beads

11.1.1.2.3. Microparticles

11.1.2. Ablation Devices

11.1.2.1. Radiofrequency (RF) Ablation Devices

11.1.2.2. Microwave Ablation Devices

11.1.2.3. Cryoablation Devices

11.1.2.4. Other Ablation Devices

11.1.3. Support Devices

11.1.3.1. Microcatheters

11.1.3.2. Guidewires

11.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Thermal Tumor Ablation

11.2.2. Non-Thermal Tumor Ablation

11.2.3. Transcatheter Arterial Chemoembolization

11.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

11.2.5. Transcatheter Arterial Embolization/Bland Embolization

11.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Liver Cancer

11.3.2. Lung Cancer

11.3.3. Bone Metastasis

11.3.4. Kidney Cancer

11.3.5. Breast Cancer

11.3.6. Prostate Cancer

11.3.7. Other Cancers

11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.4.1. Hospitals

11.4.2. Ambulatory Surgery Centers

11.4.3. Research & Academic Institutes

11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.5.1. Germany

11.5.2. UK

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Rest of Europe

11.6. Europe Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028

11.7. Europe Interventional Oncology Market Dynamics – Trends

12. Asia-Pacific Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Embolization Devices

12.1.1.1. Radioembolic Agents

12.1.1.2. Non-Radio embolic Agents

12.1.1.2.1. Microspheres

12.1.1.2.2. Coated Beads

12.1.1.2.3. Microparticles

12.1.2. Ablation Devices

12.1.2.1. Radiofrequency (RF) Ablation Devices

12.1.2.2. Microwave Ablation Devices

12.1.2.3. Cryoablation Devices

12.1.2.4. Other Ablation Devices

12.1.3. Support Devices

12.1.3.1. Microcatheters

12.1.3.2. Guidewires

12.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Thermal Tumor Ablation

12.2.2. Non-Thermal Tumor Ablation

12.2.3. Transcatheter Arterial Chemoembolization

12.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

12.2.5. Transcatheter Arterial Embolization/Bland Embolization

12.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. Liver Cancer

12.3.2. Lung Cancer

12.3.3. Bone Metastasis

12.3.4. Kidney Cancer

12.3.5. Breast Cancer

12.3.6. Prostate Cancer

12.3.7. Other Cancers

12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.4.1. Hospitals

12.4.2. Ambulatory Surgery Centers

12.4.3. Research & Academic Institutes

12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.5.1. China

12.5.2. India

12.5.3. Japan

12.5.4. ASEAN

12.5.5. Australia & New Zealand

12.5.6. Rest of Asia-Pacific

12.6. Asia-Pacific Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028

12.7. Asia-Pacific Interventional Oncology Market Dynamics – Trends

13. Latin America Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Embolization Devices

13.1.1.1. Radioembolic Agents

13.1.1.2. Non-Radio embolic Agents

13.1.1.2.1. Microspheres

13.1.1.2.2. Coated Beads

13.1.1.2.3. Microparticles

13.1.2. Ablation Devices

13.1.2.1. Radiofrequency (RF) Ablation Devices

13.1.2.2. Microwave Ablation Devices

13.1.2.3. Cryoablation Devices

13.1.2.4. Other Ablation Devices

13.1.3. Support Devices

13.1.3.1. Microcatheters

13.1.3.2. Guidewires

13.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. Thermal Tumor Ablation

13.2.2. Non-Thermal Tumor Ablation

13.2.3. Transcatheter Arterial Chemoembolization

13.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

13.2.5. Transcatheter Arterial Embolization/Bland Embolization

13.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. Liver Cancer

13.3.2. Lung Cancer

13.3.3. Bone Metastasis

13.3.4. Kidney Cancer

13.3.5. Breast Cancer

13.3.6. Prostate Cancer

13.3.7. Other Cancers

13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.4.1. Hospitals

13.4.2. Ambulatory Surgery Centers

13.4.3. Research & Academic Institutes

13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028

13.7. Latin America Interventional Oncology Market Dynamics – Trends

14. Middle East and Africa Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

14.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.1.1. Embolization Devices

14.1.1.1. Radioembolic Agents

14.1.1.2. Non-Radio embolic Agents

14.1.1.2.1. Microspheres

14.1.1.2.2. Coated Beads

14.1.1.2.3. Microparticles

14.1.2. Ablation Devices

14.1.2.1. Radiofrequency (RF) Ablation Devices

14.1.2.2. Microwave Ablation Devices

14.1.2.3. Cryoablation Devices

14.1.2.4. Other Ablation Devices

14.1.3. Support Devices

14.1.3.1. Microcatheters

14.1.3.2. Guidewires

14.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.2.1. Thermal Tumor Ablation

14.2.2. Non-Thermal Tumor Ablation

14.2.3. Transcatheter Arterial Chemoembolization

14.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

14.2.5. Transcatheter Arterial Embolization/Bland Embolization

14.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.3.1. Liver Cancer

14.3.2. Lung Cancer

14.3.3. Bone Metastasis

14.3.4. Kidney Cancer

14.3.5. Breast Cancer

14.3.6. Prostate Cancer

14.3.7. Other Cancers

14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.4.1. Hospitals

14.4.2. Ambulatory Surgery Centers

14.4.3. Research & Academic Institutes

14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.5.1. Gulf Cooperation Council (GCC) Countries

14.5.2. South Africa

14.5.3. Rest of MEA

14.6. MEA Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028

14.7. MEA Interventional Oncology Market Dynamics – Trends

15. Competition Landscape

15.1. Strategic Dashboard of Top Market Players

15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)

15.2.1. Boston Scientific Corporation

15.2.2. Medtronic PLC

15.2.3. Terumo Corporation

15.2.4. Merit Medical Systems Inc.

15.2.5. CR Bard Inc.

15.2.6. Profound Medical Corp.

15.2.7. AngioDynamics Inc.

15.2.8. Cook Medical LLC

15.2.9. HealthTronics Inc.

16. Research Methodology

17. Key Assumptions and Acronyms

Description
Reviews (0)

Description

Key development:

In 2021, Boston Scientific (US) launched the TheraSphere Y-90 Glass Microspheres.

Reviews

There are no reviews yet.

Be the first to review “Interventional Oncology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

search

Interventional Oncology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

Description

Key development:

Interventional Oncology Market

Interventional Oncology Market

Features of the Report

Product

Procedure

Cancer Type

End User

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Key development:

Reviews

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE